World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
32644
World Ranking
17834
National Ranking
8898

Overview

Thomas P. Miller is affiliated with the University of Arizona in the United States. Their research focuses primarily on the fields of Biochemistry, Genetics and Molecular Biology, as well as Agricultural and Biological Sciences.

The scientist's work encompasses several specialized subfields including Molecular Biology, Plant Science, and Cell Biology. Their research topics cover a range of areas such as Powdery Mildew Fungal Diseases, Plant Pathogens and Fungal Diseases, Plant Pathogens and Resistance, RNA and protein synthesis mechanisms, Molecular Biology Techniques and Applications, and RNA modifications and cancer.

Thomas P. Miller has contributed to multiple scientific publications. Notable recent papers include:

  • First Report of Phyllactinia chubutiana Causing Powdery Mildew on Goji Berry Plants (Lycium barbarum and L. chinense) in the United States, published in 2023 in Plant Disease
  • Simultaneous mapping of RNA secondary, tertiary, and quaternary structure in living cells by multi-site DMS probing, published in 2024 in bioRxiv (Cold Spring Harbor Laboratory)

Frequent coauthors who have collaborated with Thomas P. Miller in recent work include:

  • Karina Elfar
  • Marcelo I. Bustamante
  • S. Rooney-Latham
  • Akif Eskalen
  • Irfana Saleem

The publications of Thomas P. Miller have appeared in venues such as Plant Disease and bioRxiv (Cold Spring Harbor Laboratory).

Best Publications

  • The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma

    Andreas Rosenwald;George Wright;Wing C. Chan;Wing C. Chan;Joseph M. Connors

  • Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's Lymphoma

    Richard I. Fisher;Ellen R. Gaynor;Steve Dahlberg;Martin M. Oken

  • Stromal gene signatures in large-B-cell lymphomas

    G Lenz;G Wright;S S Dave;W Xiao

  • Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells

    Sandeep S. Dave;George Wright;Bruce Tan;Andreas Rosenwald;Andreas Rosenwald

  • Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin Lymphoma

    Andreas Rosenwald;George Wright;Karen Leroy;Xin-You Yu

  • Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

    Thomas P. Miller;Steve Dahlberg;J. Robert Cassady;David J. Adelstein

  • The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

    Andreas Rosenwald;George Wright;Adrian Wiestner;Wing C. Chan;Wing C. Chan

  • Molecular diagnosis of Burkitt's lymphoma.

    Sandeep S. Dave;Kai Fu;George W. Wright;Lloyd T. Lam

  • Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

    W. S. Dalton;T. M. Grogan;P. S. Meltzer;R. J. Scheper

  • Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience.

    D O Dixon;B Neilan;S E Jones;D A Lipschitz

  • P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.

    Thomas P. Miller;Thomas M. Grogan;William S. Dalton;Catherine M. Spier

  • New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

    Richard I. Fisher;Michael LeBlanc;Oliver W. Press;David G. Maloney

  • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.

    Lisa M. Rimsza;Robin A. Roberts;Thomas P. Miller;Joseph M. Unger

  • Phase II Trial of CHOP Chemotherapy Followed by Tositumomab/Iodine I-131 Tositumomab for Previously Untreated Follicular Non-Hodgkin's Lymphoma: Five-Year Follow-Up of Southwest Oncology Group Protocol S9911

    Oliver W. Press;Joseph M. Unger;Rita M. Braziel;David G. Maloney

  • Autologous Transplantation as Consolidation for Aggressive Non-Hodgkin's Lymphoma

    Patrick J. Stiff;Joseph M. Unger;James R. Cook;Louis S. Constine

  • Utility of Fine-Needle Aspiration As a Diagnostic Technique in Lymphoma

    Sean T. Hehn;Thomas M. Grogan;Thomas P. Miller

  • Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: A prospective Southwest Oncology Group trial

    TP Miller;TM Grogan;S Dahlberg;CM Spier

  • Phase II Study of Rituximab Plus Three Cycles of CHOP and Involved-Field Radiotherapy for Patients With Limited-Stage Aggressive B-Cell Lymphoma: Southwest Oncology Group Study 0014

    Daniel O. Persky;Joseph M. Unger;Catherine M. Spier;Baldassarre Stea

  • Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications.

    Yolanda Fernández;Monique Verhaegen;Thomas P. Miller;Jenny L. Rush

  • Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67

    Thomas M. Grogan;Scott M. Lippman;Catherine M. Spier;Donald J. Slymen

Frequent Co-Authors

Richard I. Fisher
Richard I. Fisher Fox Chase Cancer Center
Thomas M. Grogan
Thomas M. Grogan Roche (Switzerland)
Lisa M. Rimsza
Lisa M. Rimsza Mayo Clinic
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
Oliver W. Press
Oliver W. Press University of Washington
Elias Campo
Elias Campo University of Barcelona
Louis M. Staudt
Louis M. Staudt National Institutes of Health
Randy D. Gascoyne
Randy D. Gascoyne BC Cancer Agency
David G. Maloney
David G. Maloney Fred Hutchinson Cancer Research Center
Elaine S. Jaffe
Elaine S. Jaffe National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in healthcare doesn’t always mean going to medical school. Many students explore alternative routes, such as nursing, which also offer strong job prospects and flexible study options. Online programs have become increasingly popular for their convenience and affordability.

For working nurses aiming to advance, online nursing phd programs provide an accessible way to move into research or academic roles. If you’re looking to become a registered nurse, exploring the cheapest online bsn programs can help you earn your degree without the heavy financial burden.

Non-nurses who want to switch into nursing may benefit from the cheapest direct entry msn programs, designed for those holding a bachelor’s in another field. For applicants seeking less competitive entry, it’s useful to know what is the easiest nursing school to get into to jumpstart their healthcare career.

Exploring these alternative online pathways can open multiple doors in medicine and healthcare, catering to a wide range of backgrounds and career goals.

Best Scientists Citing Thomas P. Miller

Trending Scientists

Recently Published Articles